Carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone as maintenance therapy after autologous stem-cell transplantation in patients with multiple myeloma (ATLAS): interim analysis of a randomised, open-label, phase 3 trial. - Dytfeld, Dominik; Wróbel, Tomasz; Jamroziak, Krzysztof; Kubicki, Tadeusz; Robak, Paweł; Walter-Croneck, Adam; Czyż, Jarosław; Tyczyńska, Agata; Druzd-Sitek, Agnieszka; Giannopoulos, Krzysztof; Nowicki, Adam; Szczepaniak, Tomasz; et al. (Lancet Oncology, 2023)